Calendar Revolution Medicines, Inc.

Equities

RVMD

US76155X1000

Biotechnology & Medical Research

Real-time Estimate Cboe BZX Other stock markets 14:32:59 23/01/2026 GMT			5-day change	1st Jan Change
118.54 ^USD	-0.23%		-3.62%	+49.17%

01-21	RBC Boosts Price Target on Revolution Medicines to $140 From $77, Keeps Outperform, Speculative Risk	MT
01-13	Mizuho Adjusts Price Target on Revolution Medicines to $143 From $90, Maintains Outperform Rating	MT

Chart calendar Revolution Medicines, Inc.

1.QGGt53cjgu8USm4pk_8uccLYHmFhYIlVSxLNVM3DRbk.NguAgz9T15hXPhpg0Y5mF6SseSY3EdASeXiLEKrwEvF0LeeLIha2vH8YWg~8d919688cefb0a39a11827d963f18bac

Upcoming events on Revolution Medicines, Inc.

01/03/2026	Q4 2025 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
10/05/2026	Q1 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
11/08/2026	Q2 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
10/11/2026	Q3 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format

Past events on Revolution Medicines, Inc.

12/01/2026	J.P. Morgan Healthcare Conference
18/11/2025	Jefferies Global Healthcare Conference
11/11/2025	Guggenheim Healthcare Innovation Conference
05/11/2025	Q3 2025 Earnings Call
05/11/2025	Q3 2025 Earnings Release
10/09/2025	Daraxonrasib Phase 1 Clinical Trials Update Call
06/08/2025	Q2 2025 Earnings Call
06/08/2025	Q2 2025 Earnings Release
26/06/2025	Annual General Meeting
24/06/2025	Business Update Call
07/05/2025	Q1 2025 Earnings Call
07/05/2025	Q1 2025 Earnings Release
09/04/2025	Stifel Virtual Targeted Oncology Forum - Fireside Chat
07/04/2025	Needham Healthcare Conference - Fireside Chat
12/03/2025	Leerink Partners Global Healthcare Conference
11/03/2025	Barclays Global Healthcare Conference
03/03/2025	TD Cowen Healthcare Conference
26/02/2025	Q4 2024 Earnings Call
26/02/2025	Q4 2024 Earnings Release
05/02/2025	Guggenheim Securities SMID Cap Biotech Conference

Annual results

Fiscal Period	December	2022	2023	2024	2025	2026	2027
Net sales Million USD	Released Forecast Spread	35,4 27,9 26.79%	11,6 11,8 -2.05%	0,00 0,35 -	3,68	32,8	266
EBITDA Million USD	Released Forecast Spread	-253 -263 3.72%	-481 -424 -13.47%	-682 -661 -3.2%	-1 126	-1 345	-1 268
EBIT Million USD	Released Forecast Spread	-258 -269 4.04%	-487 -433 -12.56%	-690 -664 -3.91%	-1 139	-1 352	-1 255
Earnings before Tax (EBT) Million USD	Released Forecast Spread	-249 -265 5.88%	-440 -395 -11.25%	-601 -577 -4.07%	-1 067	-1 309	-1 172
Net income Million USD	Released Forecast Spread	-249 -262 5.11%	-436 -392 -11.32%	-600 -581 -3.25%	-1 064	-1 282	-1 187
EPS USD	Released Forecast Spread	-3,08 -3,28 6.06%	-3,86 -3,48 -10.99%	-3,58 -3,48 -2.9%	-5,59	-6,47	-5,77
Announcement Date		27/02/23	26/02/24	26/02/25	-

Quarterly results

Fiscal Period	September	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3	2026 Q4	2027 Q1	2027 Q2	2027 Q3
Net sales Million USD	Released Forecast Spread	0,00 0,67 -	0,00 0,81 -	0,00 0,35 -	0,00 0,35 -	0,00 0,00 -	0,00 27,5 -	0,00 1,49 -	3,68	0,00	0,00	0,00	10,3	20,0	40,0	60,0
EBITDA Million USD	Released Forecast Spread	-139 -160 13.28%	-155 -152 -2.11%	-174 -172 -1.2%	-214 -198 -8.12%	-239 -231 -3.38%	-263 -243 -8.1%	-313 -280 -11.72%	-309	-341	-358	-371	-346	-321	-305	-293
EBIT Million USD	Released Forecast Spread	-141 -139 -1.41%	-157 -148 -6.12%	-176 -167 -5.38%	-216 -189 -14.62%	-241 -219 -9.74%	-265 -211 -25.19%	-315 -285 -10.6%	-320	-327	-339	-349	-348	-322	-307	-291
Earnings before Tax (EBT) Million USD	Released Forecast Spread	-116 -118 1.33%	-133 -128 -4.15%	-156 -148 -5.41%	-195 -172 -13.58%	-213 -197 -8.15%	-248 -183 -35.27%	-305 -269 -13.37%	-308	-311	-324	-334	-333	-311	-298	-285
Net income Million USD	Released Forecast Spread	-116 -119 2.6%	-133 -128 -4%	-156 -150 -4.47%	-195 -173 -12.37%	-213 -201 -6.44%	-248 -189 -31.28%	-305 -269 -13.28%	-300	-311	-324	-334	-333	-311	-298	-285
EPS USD	Released Forecast Spread	-0,70 -0,74 4.93%	-0,81 -0,78 -3.93%	-0,94 -0,90 -4.78%	-1,12 -0,99 -12.91%	-1,13 -1,10 -3.05%	-1,31 -1,02 -28.34%	-1,61 -1,42 -13.47%	-1,58	-1,65	-1,72	-1,77	-1,73	-1,55	-1,48	-1,41
Announcement Date		08/05/24	07/08/24	06/11/24	26/02/25	07/05/25	06/08/25	05/11/25	-	-	-	-	-	-	-	-

Upcoming sector events for Revolution Medicines, Inc.

27/01/2026	LONZA GROUP AG	Q4 2025 Earnings Release	Add to your calendar Google Apple ICS format
28/01/2026	EUROFINS SCIENTIFIC SE	Q4 2025 Earnings Release	Add to your calendar Google Apple ICS format
04/02/2026	BIO-TECHNE CORPORATION	Q2 2026 Earnings Release	Add to your calendar Google Apple ICS format
04/02/2026	AZENTA, INC.	Q1 2026 Earnings Release	Add to your calendar Google Apple ICS format
04/02/2026	QIAGEN N.V.	Q4 2025 Earnings Release	Add to your calendar Google Apple ICS format
05/02/2026	IQVIA HOLDINGS INC.	Q4 2025 Earnings Release	Add to your calendar Google Apple ICS format
08/02/2026	MEDPACE HOLDINGS, INC.	Q4 2025 Earnings Release	Add to your calendar Google Apple ICS format
11/02/2026	ALKERMES PLC	Q4 2025 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
11/02/2026	BLUEPRINT MEDICINES CORPORATION	Q4 2025 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
11/02/2026	ASCENDIS PHARMA A/S	Q4 2025 Earnings Release (Projected)	Add to your calendar Google Apple ICS format

More events

Past sector events for Revolution Medicines, Inc.

Today	ONESOURCE SPECIALTY PHARMA LIMITED	Q3 2026 Earnings Release
22/01/2026	SYNGENE INTERNATIONAL LIMITED	Q3 2026 Earnings Release
19/01/2026	TELIX PHARMACEUTICALS LIMITED	Q4 2025 Earnings Release
16/01/2026	GENUS PLC	Q2 2026 Sales and Revenue Release - Trading Update
12/01/2026	SUNMAX BIOTECHNOLOGY CO., LTD.	December 2025 Sales and Revenue Release
09/01/2026	PELL BIO-MED TECHNOLOGY CO., LTD.	December 2025 Sales and Revenue Release
08/01/2026	POLARIS GROUP	December 2025 Sales and Revenue Release
24/12/2025	BRIGHT MINDS BIOSCIENCES INC.	Q4 2025 Earnings Release
15/12/2025	ABIVAX	Q3 2025 Earnings Release
11/12/2025	EVOMMUNE, INC.	Q3 2025 Earnings Release